Donate

Old name, new purpose: why we’ve gone back to RNID

  1. Home
  2. Our research into hearing loss and tinnitus
  3. Developing new treatments: the Hearing Therapeutics Initiative
  4. Hearing Therapeutics Initiative partner organisations
  5. Current research partners

Current research partners

The following companies, investors and funding bodies are working with RNID to support translational research for hearing loss and tinnitus.

Audron logo
Sensorion logo

Mundi Pharma logo
Cochlear logo
Oxford Bio Medica logo
MED-EL logo
Otonomy logo
Sound Pharmaceuticals logo

Kyorin logo
Auris Medical logo
Versant Ventures logo
Medical Research Council logo

GSK logo
Spiral Therapeutics logo
Autifony Therapeutics logo
Decibel Therapeutics
MSD logo

Page last updated: 16 November 2020

Back to top